Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a local twist on the mediterranean diet help obese women shed pounds?

NCT ID NCT07461870

Disease control Sponsor: Indonesia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a Mediterranean diet adapted to use local Indonesian foods can help obese women lose weight and improve health markers like inflammation and gut bacteria. Fifty-four women will follow either this diet or a standard low-calorie diet for 4 weeks. Researchers will measure changes in body composition, blood markers, and gut microbiota.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mediterranean diet adapted to local Indonesian foods
What this could lead to
If successful, this could show that a culturally adapted Mediterranean diet helps with weight loss and reduces inflammation in obese individuals.
What could go wrong
This is a small, early-stage study with only 54 participants, all women, so results may not apply broadly. Dietary compliance and short duration (4 weeks) limit conclusions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Dec 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women who were obese, as defined by a BMI of at least 27. * Aged 18-50 years * Subjects with a non-shift work schedule * Willing to follow the research procedures and sign the informed consent form. Exclusion Criteria: * Subjects with a history of type 2 diabetes, kidney disease, liver disease, or thyroid disorders, as indicated by medical history or medical records. * Contraindications for the MF-BIA examination include the use of pacemakers or implants and a history of amputation. * Pregnant or within 40 days of childbirth * Adults with edema * Taking medications with hyperglycemic effects, such as beta-blockers, thiazides, corticosteroids, calcineurin inhibitors, anti-dyslipidemic medications (e.g., statins, fibrates, niacin, and bile acid sequestrants), or antibiotics. * History of food allergies

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obese subjects are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obese subjects

Contacts and locations

Locations

  • Department of Nutrition, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia

    Jakarta Pusat, Jakarta Special Capital Region, 10430, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.